| 标题 |
KRAS mutation-driven O-GlcNAcylation of CLDN18.2 enhances the progression of pancreatic cancer and reduces the efficacy of CLDN18.2-targeted therapy |
| 网址 | |
| DOI | |
| 其它 |
期刊:Gut 作者:Liu J; Hou X; Li L; Bai W; Zhou T; et al 出版日期:2026/01/09 |
| 求助人 | |
| 下载 |